These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 20381170)
61. Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting. Letmaier M; Schreinzer D; Reinfried L; Glauninger G; Thierry N; Kapitany T; Kasper S Int J Neuropsychopharmacol; 2006 Oct; 9(5):529-37. PubMed ID: 16191207 [TBL] [Abstract][Full Text] [Related]
62. Mood stabilizer augmentation with olanzapine in acutely manic children. Chang KD; Ketter TA J Child Adolesc Psychopharmacol; 2000; 10(1):45-9. PubMed ID: 10755582 [TBL] [Abstract][Full Text] [Related]
63. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. Jornada LK; Valvassori SS; Steckert AV; Moretti M; Mina F; Ferreira CL; Arent CO; Dal-Pizzol F; Quevedo J J Psychiatr Res; 2011 Feb; 45(2):162-8. PubMed ID: 20627318 [TBL] [Abstract][Full Text] [Related]
64. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder. Gulack BC; Puri NV; Kim WJ Ann Pharmacother; 2011 Oct; 45(10):e57. PubMed ID: 21917558 [TBL] [Abstract][Full Text] [Related]
65. Are migraine and bipolar disorders comorbid phenomena?: findings from a pharmacoepidemiological study using the Norwegian Prescription Database. Oedegaard KJ; Dilsaver SC; Hundal O; Riise T; Lund A; Akiskal HS; Fasmer OB J Clin Psychopharmacol; 2011 Dec; 31(6):734-9. PubMed ID: 22020352 [TBL] [Abstract][Full Text] [Related]
66. No correlation between lithium serum levels and psychopathological features during the euthymic interval of patients with recurrent affective disorder. Lewitzka U; Scheffczyk R; Ritter D; Doucette S; Bauer M; Bschor T Pharmacopsychiatry; 2012 Jan; 45(1):1-6. PubMed ID: 21989601 [TBL] [Abstract][Full Text] [Related]
67. Observational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment setting. Woo YS; Bahk WM; Pae CU; Jeong JH; Koo BH; Jon DI; Lee JG; Kim MD Asia Pac Psychiatry; 2014 Sep; 6(3):334-41. PubMed ID: 24038834 [TBL] [Abstract][Full Text] [Related]
68. Medical and substance use comorbidity in bipolar disorder. Kemp DE; Gao K; Ganocy SJ; Caldes E; Feldman K; Chan PK; Conroy C; Bilali S; Findling RL; Calabrese JR J Affect Disord; 2009 Jul; 116(1-2):64-9. PubMed ID: 19100627 [TBL] [Abstract][Full Text] [Related]
69. Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. Chen ST; Altshuler LL; Melnyk KA; Erhart SM; Miller E; Mintz J J Clin Psychiatry; 1999 Mar; 60(3):181-6. PubMed ID: 10192594 [TBL] [Abstract][Full Text] [Related]
71. Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes. Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Akiskal HS J Child Adolesc Psychopharmacol; 2004; 14(3):395-404. PubMed ID: 15650495 [TBL] [Abstract][Full Text] [Related]
72. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers. Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717 [TBL] [Abstract][Full Text] [Related]
73. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Post RM; Leverich GS; Kupka R; Keck PE; McElroy SL; Altshuler LL; Frye MA; Rowe M; Grunze H; Suppes T; Nolen WA Compr Psychiatry; 2016 Apr; 66():146-56. PubMed ID: 26995248 [TBL] [Abstract][Full Text] [Related]
74. Lithium treatment of a bipolar patient with Wilson's disease: a case report. Rybakowski JK; Litwin T; Chlopocka-Wozniak M; Czlonkowska A Pharmacopsychiatry; 2013 May; 46(3):120-1. PubMed ID: 23037949 [TBL] [Abstract][Full Text] [Related]
75. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. Potter MP; Liu HY; Monuteaux MC; Henderson CS; Wozniak J; Wilens TE; Biederman J J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):529-38. PubMed ID: 19877977 [TBL] [Abstract][Full Text] [Related]
76. Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics. Carli M; Weiss F; Grenno G; Ponzini S; Kolachalam S; Vaglini F; Viaggi C; Pardini C; Tidona S; Longoni B; Maggio R; Scarselli M Curr Neuropharmacol; 2023; 21(4):935-950. PubMed ID: 36825703 [TBL] [Abstract][Full Text] [Related]
77. Suicidality, bipolar disorders, and pharmacotherapy. Bronisch T; Wolfersdorf M; Leenaars A Arch Suicide Res; 2005; 9(3):231-5. PubMed ID: 16020166 [TBL] [Abstract][Full Text] [Related]
78. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798 [TBL] [Abstract][Full Text] [Related]
79. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Lyoo IK; Dager SR; Kim JE; Yoon SJ; Friedman SD; Dunner DL; Renshaw PF Neuropsychopharmacology; 2010 Jul; 35(8):1743-50. PubMed ID: 20357761 [TBL] [Abstract][Full Text] [Related]
80. The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. Reilly-Harrington NA; Sylvia LG; Leon AC; Shesler LW; Ketter TA; Bowden CL; Calabrese JR; Friedman ES; Ostacher MJ; Iosifescu DV; Rabideau DJ; Thase ME; Nierenberg AA J Psychiatr Res; 2013 Nov; 47(11):1686-93. PubMed ID: 23911057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]